Penn reports strong demand for its pharmaceutical services
This article was originally published in Scrip
Executive Summary
The Wales-based firm, Penn Pharmaceutical Services, has reported full-year revenues of £23.3 million, a 34% increase on those a year ago. The company notes that the strong demand for its formulation, development and custom manufacturing services has led to it appointing 43 new employees over the past year, and the opening of new high potency drug and warehousing facilities. Penn is also growing its presence on the east and west coasts of the US, and in Japan.